- Home
- SBH vs COLL Comparison
SBH vs COLL Comparison
Compare SBH & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- COLL
- Stock Information
- Founded
- SBH 1964
- COLL 2002
- Country
- SBH United States
- COLL United States
- Employees
- SBH N/A
- COLL N/A
- Industry
- SBH Other Specialty Stores
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- SBH Consumer Discretionary
- COLL Health Care
- Exchange
- SBH Nasdaq
- COLL Nasdaq
- Market Cap
- SBH 940.7M
- COLL 1.0B
- IPO Year
- SBH 2006
- COLL 2015
- Fundamental
- Price
- SBH $8.94
- COLL $29.13
- Analyst Decision
- SBH Buy
- COLL Strong Buy
- Analyst Count
- SBH 6
- COLL 5
- Target Price
- SBH $12.70
- COLL $43.60
- AVG Volume (30 Days)
- SBH 2.7M
- COLL 304.0K
- Earning Date
- SBH 02-13-2025
- COLL 02-27-2025
- Dividend Yield
- SBH N/A
- COLL N/A
- EPS Growth
- SBH 4.93
- COLL 757.11
- EPS
- SBH 1.66
- COLL 2.16
- Revenue
- SBH $3,723,624,000.00
- COLL $599,245,000.00
- Revenue This Year
- SBH $0.99
- COLL $13.25
- Revenue Next Year
- SBH $1.73
- COLL $17.67
- P/E Ratio
- SBH $5.39
- COLL $13.47
- Revenue Growth
- SBH 0.57
- COLL 9.62
- 52 Week Low
- SBH $8.88
- COLL $28.39
- 52 Week High
- SBH $14.79
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- SBH 29.99
- COLL 37.61
- Support Level
- SBH $9.03
- COLL $29.39
- Resistance Level
- SBH $9.67
- COLL $30.39
- Average True Range (ATR)
- SBH 0.51
- COLL 1.00
- MACD
- SBH -0.07
- COLL -0.24
- Stochastic Oscillator
- SBH 2.91
- COLL 11.04
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.